LTR Pharma
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9/204 Alice St, Brisbane, Queensland, 40...Phone Number
+61 1800519711Website
www.ltrpharma.comRevenue
-Stock Symbol
LTPIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About LTR Pharma
LTR Pharma is a clinical stage biopharmaceutical company founded in 2020 that has developed a novel intranasal drug platform called SPONTAN, designed to treat erectile dysfunction in 10 minutes or less. The company's innovative treatment offers rapid onset action with lower doses to reduce side effects, promoting spontaneous interactions. LTR Pharma is commercializing this first-in-class treatment and has established distribution agreements to facilitate its market entry. The company focuses on pharmaceutical manufacturing and is working to bring innovative medical solutions to market.Explore more
LTR Pharma Org Chart
GS
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LTR Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
LTR Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when LTR Pharma launches new products
Click to see if LTR Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at LTR Pharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if LTR Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if LTR Pharma is spiking on competitors!
Earning: See what the market has to say on LTR Pharma recently announced quarterly report
Funding: Get notified immidiatlly once LTR Pharma has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to LTR Pharma
Compare insights from companies similar to LTR Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
LTR Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LTR Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LTR Pharma.
LTR Pharma financials insights
Gather financial insights about LTR Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Share Placement
$10.5M
LTR Pharma Tech Stack
A closer look at the technologies used by LTR Pharma
See more technologies
LTR Pharma News & Media
SPONTAN® Phase II interim data demonstrates rapid onset and pharmacokinetic profile addressing FDA Pre-IND requirements across adult and ≥65 populations
Highlights Median Tmax of 10 minutes for SPONTAN® (5 mg) versus 60 minutes for oral vardenafil (20mg), consistent with Phase I study. Interim data provide the key pharmacokinetic dataset requested by the FDA, including rapid absorption, repeat-dose profile, with no drug accumulation observed, and consistent pharmacokinetics across adult and geriatric populations. Pharmacokinetic profile in subjects ≥65 years comparable to adults in the dataset, addressing a key FDA Pre-IND requirement. ConsistenLevOmega Pty Ltd announced that it has received AUD 1 million in funding from LTR Pharma Limited
LevOmega Pty Ltd announced that it has received AUD 1 million in a round of funding on October 6, 2025. The transaction included participation from returning investor LTR Pharma Limited, through its...LTR Pharma deepens stake in LevOmega to accelerate sustainable Omega-3 development
LTR Pharma (ASX:LTP) has increased its ownership in sustainable biotechnology company LevOmega from 33 to approximately 43 per cent, following a $1 million strategic investment through its subsidiary LTR Spectrum.LTR Pharma (ASX:LTP) Boosts Stake in LevOmega to 43% with New $1m Strategic ...
6 October 2025 – Sydney, Australia | LTR Pharma Limited (ASX:LTP) has increased its ownership in LevOmega Pty Ltd from 33% to ~43% via a strategic $1 million investment. The additional stake was acquired via the Company’s wholly-owned subsidiary, LTR Spectrum Pty Ltd, and follows LevOmega’s successful capital raising to progress its research and development
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding LTR Pharma
Sign Up For FreeTo access detailed company insights
LTR Pharma is a clinical stage biopharmaceutical company founded in 2020 that has developed a novel intranasal drug platform called SPONTAN, designed to treat erectile dysfunction in 10 minutes or less. The company's innovative treatment offers rapid onset action with lower doses to reduce side effects, promoting spontaneous interactions. LTR Pharm... Read More
